NCT00456287|UnknownDMC
Loading search results
Sponsor study identifier
interventional
40
1 country
1
Study Start
February 2007
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
Not reported
Date not reportedThe objective of the study is to define and compare clotting- fibrinolysis patterns, platelet function markers and endothelial dysfunction in patients with SAHS before and after treatment and normal controls age and weight matched.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 2007
Date type not reportedThis date has not been verified as actual or estimated.
April 2, 2007
Actual (reported)April 4, 2007
Actual (reported)To define and compare clotting- fibrinolysis patterns, platelet function markers and endothelial dysfunction
CPAP (Continuous Positive Airway Pressure) effect on studied variables
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Hospital Universitario Son Dureta
Palma de Mallorca, Balearic Islands, 07014, Spain
Antonia Barceló, MD
Hospital Universitario Son Dureta
First Submitted
April 2, 2007
First Posted
April 4, 2007
Study Start
February 2007
Date type not reportedThis date has not been verified as actual or estimated.
Last Updated
April 4, 2007
Record last verified: 2007-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved:
Contact the study team to confirm eligibility.